92 results
8-K
EX-99.1
INMB
INmune Bio Inc
30 Apr 24
Other Events
4:01pm
(mCRPC). The Company is pleased to announce the successful completion of the first cohort in the trial. Following review by the Safety Review Committee … without the need for conditioning therapy, pre-medication, or cytokine support.
“We are pleased with the safety of INKmune in men with mCRPC
8-K
EX-10.1
INMB
INmune Bio Inc
26 Apr 24
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:28pm
, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety … , product quality and safety and employment and labor matters, except in each case of (i), (ii) and (iii) as could not have or reasonably be expected
424B5
INMB
INmune Bio Inc
26 Apr 24
Prospectus supplement for primary offering
4:26pm
the risk of infection, cancer and demyelinating neurologic diseases, respectively; these safety problems are due to off-target effects on inhibiting tmTNF … ) adequate steps have not been taken to commercialize the invention; (2) government action is necessary to meet public health or safety needs; or (3
8-K
EX-10.1
INMB
INmune Bio Inc
22 Apr 24
Entry into a Material Definitive Agreement
5:10pm
, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment
424B5
rti70vm
22 Apr 24
Prospectus supplement for primary offering
5:09pm
8-K
EX-99.1
u7s3 beechcom01vb
29 Mar 24
INmune Bio Inc. Announces Year End 2023 Results and Provides a Q4 Business Update
4:01pm
8-K
EX-99.1
6wrtgq ays7g
2 Jan 24
INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer
4:00pm
8-K
EX-99.2
luk3am3t8gg24j
31 Oct 23
Regulation FD Disclosure
4:25pm
424B5
q8bl9
16 Aug 23
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.2
7iw4xson
12 Jul 23
Other Events
12:00am
8-K
EX-99.1
otpdyz203lw
12 May 23
HARNESSING THE POWER OF THE INNATE IMMUNE SYSTEM INMB Webinar Phase I/II Trial of INKmune ʳ in Metastatic Castration - Resistant Prostate Cancer
8:00am
8-K
EX-99.1
d8e7wcqav85 khmacz
8 May 23
Other Events
8:02am
8-K
EX-99.1
8vavb7fgk 5vxelzc1re
3 Apr 23
Other Events
9:12am
8-K
EX-99.1
kjn60 pdrnp
4 Nov 22
Other Events
4:43pm